The extended leukocyte differential count using the Cytodiff flow cytometric system reveals that higher CD16+ cytotoxic NK+T lymphocyte levels predict superior survival outcomes in patients with metastatic carcinoma

Cytometry Part B - Clinical Cytometry

Volumn 84 B, Issue 3, 2013, Pages 202-204

  Park, Borae G ^a   Park, Chan Jeoung ^a   Yoon, Chan Hee ^a   Jang, Seongsoo ^a   Chi, Hyun Sook ^a   Ryu, Min Hee ^a   Kim, Sang We ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

CD16; Cytodiff; NK cell; NK+T cell; prognosis

Indexed keywords

CD16 ANTIGEN;

ARTICLE; BLOOD SAMPLING; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; LUNG CANCER; MALE; PRIORITY JOURNAL; STOMACH CANCER; TREATMENT OUTCOME;

CARCINOMA; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GPI-LINKED PROTEINS; HUMANS; IMMUNOPHENOTYPING; KAPLAN-MEIER ESTIMATE; KILLER CELLS, NATURAL; LEUKOCYTE COUNT; LUNG NEOPLASMS; MALE; NEOPLASM METASTASIS; PREDICTIVE VALUE OF TESTS; RECEPTORS, IGG; STOMACH NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 84876471729     PISSN: 15524949     EISSN: 15524957     Source Type: Journal    
DOI: 10.1002/cyto.b.21063     Document Type: Article

References (6)

1. Molling JW, Langius JA, Langendijk JA, Leemans CR, Bontkes HJ, van der Vliet HJ, von Blomberg BM, Scheper RJ, van den Eertwegh AJ,. Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma. J Clin Oncol 2007; 25: 862-868.
2. Fregni G, Perier A, Pittari G, Jacobelli S, Sastre X, Gervois N, Allard M, Bercovici N, Avril MF, Caignard A,. Unique functional status of natural killer cells in metastatic stage IV melanoma patients and its modulation by chemotherapy. Clin Cancer Res 2011; 17: 2628-2637.
3. Qiu H, Xiao-Jun W, Zhi-Wei Z, Gong C, Guo-Qiang W, Li-Yi Z, Yuan-Fang L, Rajiv-Prasad K,. The prognostic significance of peripheral T-lymphocyte subsets and natural killer cells in patients with colorectal cancer. Hepatogastroenterology 2009; 56: 1310-1315.
4. Faucher JL, Lacronique-Gazaille C, Frebet E, Trimoreau F, Donnard M, Bordessoule D, Lacombe F, Feuillard J., "6 markers/5 colors" extended white blood cell differential by flow cytometry. Cytometry A 2007; 71A: 934-944.
5. Takeuchi H, Maehara Y, Tokunaga E, Koga T, Kakeji Y, Sugimachi K,. Prognostic significance of natural killer cell activity in patients with gastric carcinoma: A multivariate analysis. Am J Gastroenterol 2001; 96: 574-578.
6. Terme M, Ullrich E, Delahaye NF, Chaput N, Zitvogel L,. Natural killer cell-directed therapies: Moving from unexpected results to successful strategies. Nat Immunol 2008; 9: 486-494.